Company Overview

Cardinal Health, Inc. is a U.S.-based healthcare services and products company that operates primarily in pharmaceutical distribution, medical products, and supply chain solutions. The company serves hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and other healthcare providers. Its operations are concentrated in the healthcare supply chain industry, with core activities involving pharmaceutical sourcing and distribution, medical product manufacturing and distribution, and healthcare logistics services. According to disclosures in SEC filings and company investor materials, pharmaceutical distribution represents the company’s largest revenue contributor by a significant margin.

The company’s primary business lines include the Pharmaceutical and Specialty Solutions segment and the Global Medical Products and Distribution segment. Revenue is generated through branded and generic pharmaceutical distribution, specialty pharmaceutical services, at-home healthcare products, medical and surgical product distribution, and inventory management services. Cardinal Health has developed a large-scale logistics network and long-standing relationships with manufacturers, pharmacies, and provider organizations, which contribute to its competitive positioning in the U.S. healthcare supply chain. Founded in 1971 by Robert D. Walter in Ohio as a food wholesaler named Cardinal Foods, the company evolved through acquisitions and expansion into healthcare distribution during the 1980s and 1990s, becoming one of the largest healthcare distributors in the United States.

Business Operations

Cardinal Health organizes its operations primarily through two reportable segments: Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution. The Pharmaceutical and Specialty Solutions segment distributes branded, generic, specialty, and over-the-counter pharmaceuticals to retail chains, independent pharmacies, hospitals, and healthcare providers. It also includes nuclear pharmacy services, specialty physician support, and manufacturer services. The Global Medical Products and Distribution segment distributes Cardinal Health-branded and third-party medical, surgical, and laboratory products, including gloves, surgical apparel, fluid management products, and supply chain solutions for healthcare providers.

The company operates extensive domestic distribution infrastructure throughout the United States and maintains international activities in select markets including Canada, Europe, and Asia. Cardinal Health controls large-scale warehousing, logistics, and inventory management systems designed to support rapid pharmaceutical delivery and medical supply fulfillment. Major subsidiaries and business platforms include NaviHealth (historically associated with care coordination investments before divestiture activity), Nuclear & Precision Health Solutions, and specialty pharmaceutical operations. Strategic partnerships with pharmaceutical manufacturers, group purchasing organizations, and healthcare systems are central to its operating model. Public filings and industry reporting also identify relationships with pharmaceutical manufacturers and retail pharmacy chains as critical drivers of scale and operational efficiency.

Strategic Position & Investments

Cardinal Health’s strategic direction has focused on strengthening pharmaceutical distribution efficiency, expanding specialty healthcare services, and improving profitability within medical products operations. The company has emphasized growth in specialty pharmaceuticals, at-home healthcare services, and advanced supply chain capabilities. Recent strategic initiatives highlighted in earnings materials and investor presentations include investments in specialty drug distribution, oncology and urology platform expansion, and technology-enabled supply chain management solutions. The company has also pursued operational restructuring efforts intended to improve margins in its medical products business.

Cardinal Health has completed several acquisitions and portfolio investments aimed at expanding specialty and physician-focused services. Notable transactions in recent years include the acquisition of Integrated Oncology Network and investments associated with specialty physician enablement and outpatient care platforms. The company has also maintained involvement in emerging healthcare delivery sectors such as precision health, specialty infusion support, and data-enabled healthcare logistics. While Cardinal Health continues to evaluate acquisitions and portfolio optimization opportunities, some strategic investment details vary across reporting periods, and certain long-term investment outcomes remain dependent on market and regulatory conditions.

Geographic Footprint

Cardinal Health is headquartered in Dublin, Ohio, and derives the substantial majority of its revenue from operations in the United States. The company maintains a nationwide logistics and distribution network serving healthcare providers and pharmacies across all major U.S. regions. Its pharmaceutical distribution infrastructure includes large-scale distribution centers, specialty pharmacies, and nuclear pharmacy locations that support time-sensitive healthcare delivery requirements.

Outside the United States, Cardinal Health maintains operations and commercial activities in Canada, Europe, and parts of Asia-Pacific, particularly through medical products distribution and sourcing activities. The company’s international footprint is smaller relative to its domestic business but supports global procurement, manufacturing partnerships, and selected healthcare distribution services. Public disclosures indicate that international operations contribute a modest portion of total revenue compared with U.S. operations, though the company continues to maintain cross-border sourcing and operational capabilities to support its healthcare supply chain functions.

Leadership & Governance

Cardinal Health’s governance structure includes an executive leadership team with experience across healthcare distribution, finance, supply chain operations, and pharmaceutical services. The company emphasizes operational discipline, healthcare accessibility, and supply chain reliability as core elements of its leadership philosophy. Strategic priorities communicated by management include sustainable earnings growth, disciplined capital allocation, and expansion in specialty healthcare markets. Founder Robert D. Walter played a major role in transforming the company from a regional food wholesaler into a healthcare distribution enterprise through aggressive acquisition-driven expansion.

Key executives identified in recent company filings and investor disclosures include:

• Jason M. Hollar – Chief Executive Officer
• Aaron Alt – Chief Financial Officer
• Debbie Weitzman – Chief Executive Officer, Pharmaceutical and Specialty Solutions
• Jon Giacomin – Chief Executive Officer, Medical Segment
• Michelle Greene – Chief Information Officer
• Stephen Mason – Chief Human Resources Officer
• Jessica L. Mayer – Chief Legal and Compliance Officer

Leadership information and organizational structure have been verified against recent SEC filings, annual reports, and company investor relations disclosures. Titles and executive responsibilities may change over time based on corporate governance updates and management transitions.